Gradient Investments LLC Gilead Sciences, Inc. Transaction History

Gradient Investments LLC

$3.79 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$63.15 - $72.88 $22,355 - $25,799	354 Added 133.58%	619 $42,000
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $17,680 - $21,560	-247 Reduced 48.24%	265 $19,000
Q4 2023 Jan 18, 2024	BUY	$73.27 - $83.09 $439 - $498	6 Added 1.19%	512 $41,000
Q3 2023 Oct 27, 2023	SELL	$73.94 - $80.67 $443 - $484	-6 Reduced 1.17%	506 $37,000
Q2 2023 Jul 11, 2023	SELL	$76.01 - $86.7 $10,109 - $11,531	-133 Reduced 20.62%	512 $39,000
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $8,890 - $10,129	-115 Reduced 15.13%	645 $53,000
Q4 2022 Jan 10, 2023	SELL	$62.32 - $89.47 $6,107 - $8,768	-98 Reduced 11.42%	760 $0
Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $11,550 - $13,193	-194 Reduced 18.44%	858 $53,000
Q2 2022 Jul 11, 2022	BUY	$57.72 - $65.01 $11,717 - $13,197	203 Added 23.91%	1,052 $65,000
Q1 2022 May 26, 2022	SELL	$57.92 - $72.58 $3,880 - $4,862	-67 Reduced 7.31%	849 $50,000
Q4 2021 Jan 12, 2022	BUY	$64.88 - $73.64 $8,953 - $10,162	138 Added 17.74%	916 $67,000
Q3 2021 Oct 18, 2021	SELL	$67.69 - $73.03 $5,550 - $5,988	-82 Reduced 9.53%	778 $54,000
Q2 2021 Jul 12, 2021	SELL	$63.47 - $69.35 $380 - $416	-6 Reduced 0.69%	860 $59,000
Q1 2021 Apr 21, 2021	BUY	$60.0 - $68.46 $31,080 - $35,462	518 Added 148.85%	866 $56,000
Q3 2020 Oct 06, 2020	SELL	$62.1 - $78.08 $31,174 - $39,196	-502 Reduced 59.06%	348 $22,000
Q2 2020 Jul 10, 2020	BUY	$72.34 - $84.0 $45,791 - $53,172	633 Added 291.71%	850 $65,000
Q1 2020 Apr 07, 2020	SELL	$62.63 - $80.22 $1.59 Million - $2.04 Million	-25,443 Reduced 99.15%	217 $16,000
Q4 2019 Jan 15, 2020	BUY	$61.62 - $67.78 $195,581 - $215,133	3,174 Added 14.12%	25,660 $1.67 Million
Q3 2019 Oct 10, 2019	BUY	$62.51 - $69.0 $318,926 - $352,038	5,102 Added 29.35%	22,486 $1.43 Million
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $835,492 - $936,907	13,504 Added 348.04%	17,384 $1.17 Million
Q1 2019 Apr 11, 2019	BUY	$62.53 - $70.05 $175,334 - $196,420	2,804 Added 260.59%	3,880 $252,000
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $9,020 - $11,771	149 Added 16.07%	1,076 $67,000
Q3 2018 Oct 11, 2018	BUY	$71.28 - $78.92 $28,512 - $31,568	400 Added 75.9%	927 $72,000
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $1,167 - $1,362	-18 Reduced 3.3%	527 $37,000
Q1 2018 Apr 11, 2018	BUY	$72.84 - $88.8 $3,204 - $3,907	44 Added 8.78%	545 $41,000
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $35,646 - $41,843	501	501 $36,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account